Progenics Pharmaceuticals Inc. (PGNX) Major Shareholder Sells $5,821,116.00 in Stock
Progenics Pharmaceuticals Inc. major shareholder Healthcare Master Fun Broadfin sold 602,600 shares of the firm's stock in a transaction dated Wednesday, February 15th. The shares were sold at an average price of $9.66, for a total value of $5,821,116.00.
from Biotech News
0 Comments